Novo Nordisk A/S

Healthcare · Drug Manufacturers - General

37.30$ -0.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Novo Nordisk A/S (NVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 542,902 million DKK. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of DKK.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NVO
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	21,047	25,686	27,340	31,043	24,601	28,830	31,453	34,489	37,696	41,896	44,696	47,795	50,726	54,742	61,402	64,698	65,669	70,337	77,062	91,799	97,539	102,355	110,769	18,869	23,822	194,508	241,257	314,486	465,795	542,902
Current Assets	9,753	12,842	13,063	15,932	12,529	13,826	13,752	16,301	17,874	19,530	20,839	24,332	29,137	32,666	37,293	39,591	40,163	42,058	46,293	55,140	59,766	60,080	59,067	9,382	10,818	85,595	108,194	139,646	160,897	172,453
Cash	1,572	1,123	799	1,974	1,275	1,654	1,423	1,265	3,457	3,297	3,272	4,828	8,805	11,296	12,017	13,408	11,553	10,728	14,396	16,923	18,690	18,852	15,638	2,325	2,097	10,720	12,653	14,392	15,655	26,464
Cash & Short-Term Investments	1,572	1,123	799	1,974	1,275	3,049	1,741	3,098	3,990	5,018	5,102	7,385	10,185	12,826	16,051	17,502	16,105	14,469	15,905	20,465	20,699	18,852	15,638	2,325	2,097	17,485	23,574	30,230	26,308	26,962
Receivables	4,624	4,770	5,705	6,528	4,708	6,032	4,700	4,387	4,571	6,121	6,498	7,313	8,725	9,133	10,936	11,673	12,551	11,606	15,791	17,742	24,197	23,551	26,889	3,863	4,606	46,799	57,505	75,261	87,414	75,697
Inventory	2,510	2,716	4,642	4,887	3,970	4,745	5,910	6,551	7,211	7,773	8,397	9,031	9,634	10,016	9,689	9,433	9,543	9,552	11,357	12,758	14,341	15,373	16,336	2,650	3,047	19,621	24,388	31,811	40,849	49,623
Property, Plant & Equipment	–	–	–	–	1,372	1,631	2,287	2,845	3,196	3,166	3,603	3,841	3,484	3,704	3,650	3,653	3,808	4,043	3,760	25,545	30,179	35,247	41,891	50,551	50,269	55,362	66,671	90,961	162,488	208,378
Goodwill	–	–	–	–	3.5	1.4	33	36	4.6	2.7	17	66	13	14	70	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	4,346	5,092	4,464	20,064	19,845
Intangible Assets	220	257	237	177	32	17	241	219	318	485	622	603	792	1,037	1,388	1,489	1,495	1,615	1,378	2,158	2,714	3,325	5,145	877	3,396	38,825	46,324	55,942	91,026	110,208
Total Liabilities	5,023	7,512	9,305	12,413	8,855	8,747	8,557	9,194	11,009	14,304	14,567	15,572	17,668	19,008	24,437	27,250	25,037	27,768	36,768	44,830	52,270	52,540	58,930	10,218	13,413	123,762	157,771	207,925	322,309	348,855
Current Liabilities	3,674	5,315	5,486	6,565	6,417	5,990	5,959	6,646	7,332	10,565	10,160	10,658	12,988	13,415	18,476	20,779	21,638	24,225	33,689	40,873	47,436	47,056	54,164	8,860	11,551	99,516	120,940	169,655	217,528	215,661
Short-Term Debt	118	1,340	923	1,146	818	827	566	976	510	1,444	339	404	1,337	418	1,720	351	500	2,207	720	1,073	229	1,694	515	221	1,226	13,684	1,466	6,478	13,113	12,017
Accounts Payable	782	581	771	806	979	969	863	1,011	1,070	1,500	1,712	1,948	2,284	2,242	2,906	3,291	3,859	4,092	4,950	4,927	6,011	5,610	6,756	955	940	8,870	15,587	25,606	28,846	19,758
Long-Term Debt	–	–	–	–	120	103	116	127	216	198	208	188	183	187	90	88	–	–	–	0.0	0.0	0.0	0.0	0.0	–	9,654	20,775	15,976	84,246	118,941
Shareholders' Equity	16,015	18,119	17,971	18,556	15,746	20,083	22,896	25,295	26,687	27,593	30,129	32,223	33,058	35,734	36,965	37,448	40,632	42,569	40,294	46,969	45,269	49,815	51,839	8,651	10,409	70,746	83,486	106,561	143,486	194,047
Retained Earnings	12,609	14,593	14,457	14,690	12,353	16,416	19,025	21,150	22,829	26,924	28,812	30,699	33,513	35,146	36,097	37,111	39,001	41,137	41,277	46,816	46,111	48,977	53,406	8,685	10,483	72,004	80,587	104,839	144,448	195,298
Shares Outstanding	7,472	7,537	7,350	7,020	6,940	6,936	6,982	6,880	6,790	6,589	6,459	6,357	6,226	6,043	5,855	5,701	5,517	5,387	5,260	5,157	5,070	4,956	4,849	4,757	4,680	4,606	4,545	4,495	4,463	4,448

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings